Lung function in type 1 Saudi diabetic patients

Saudi Medical Journal

Volumn 26, Issue 11, 2005, Pages 1728-1733

  Meo, Sultan A ^a   Al Drees, Abdul M ^a   Shah, Sayed F A ^a   Arif, Mohammad ^a   Al Rubean, Khalid ^b  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; SAUDI ARABIA; SPIROMETRY; STUDENT T TEST;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES; MALE; PEAK EXPIRATORY FLOW RATE; PROBABILITY; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 28844501857     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Viberti GC. Rosiglitazone: Potential beneficial impact on cardiovascular disease. Int J Clinc Pract 2003; 57: 128-134.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 13, 414: 782-787.
3. Onkamo P, Vaananen S, Karvonen M, Tuomilehto, J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999; 42: 1395-1403.
4. Khan LA. Diabetes mellitus an evolving epidemic. The Practitioner 1999; 10: 3.
5. Amos AF, Mc Carty DJ, Zimmer P. The rising global burden of Diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997; 14: S7-S85.
6. Al-Daghri N, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, Kumar S. Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diabet Med 2003; 20: 832-837.
7. Committee report. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 25: S5-S20.
8. Boulbou MS, Gourgoulianis KI, Klisiaris VK, Tsikrikas TS, Stathakis NE, Molyvdas PA. Diabetes mellitus and lung function. Med Princ Pract 2003; 12: 87-91.
9. Sandler M, Bunn AE, Stewart RI. Pulmonary function in young insulin-dependent diabetic subjects. Chest 1986; 90: 670-675.
10. Matsubara T, Hara F. The pulmonary function and histopathological studies of the lung in diabetes mellitus. Nippon Ika Daigaku Zasshi 1991; 58: 528-536.
11. Ljubic S, Metelko Z, Car N, Roglic G, Drazic Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998; 114: 1033-1035.
12. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15: 205-218.
13. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002; 25: 458-463.
14. Jacobs J, Sena M, Fox N. The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med 1991; 8: S23-S29.
15. Schernthaner G, Haber P, Kummer F, Ludwig H. Lung elasticity in juvenile-onset diabetes mellitus. Am Rev RespirDis 1977; 116: 544-546.
16. Primhak RA, Whincup G, Tsanakas JN, Milner RD. Reduced vital capacity in insulin-dependent diabetes. Diabetes 1987; 36: 324-326.
17. Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989; 2: 14-19.
18. Cotes JE. Lung function, assessment and application in medicine. 5th ed. Blackwell, Oxford; 1993. p. 492-493.
19. Glindmeyer JW, Lefante JJ, Jones RN, Rando RJ, Weill H. Cotton dust and cross shift change in FEV1 as predictors of annual change in FEV1. Am J Resp Crit Care Med 1994; 149: 584-590.
20. American Thoracic Society. American Thoracic Society Statement-Standardization of Spirometry. Am Rev Respir Dis 1987; 136: 1285-1298.
21. Asanuma Y, Fujiya S, Ide H, Agishi Y. Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clin Pract 1985; 1: 95-101.
22. Cazzato S, Bernardi F, Salardi S, Tassinari D, Corsini I, Ragni L, et al. Lung function in children with diabetes mellitus. Pediatr Pulmonol 2004; 37: 17-23.
23. Benbassat CA, Stern E, Kramer M, Lebzelter J, Blum I, Fink G. Pulmonary function in patients with diabetes mellitus. Am J Med Sci 2001; 322: 127-132.
24. Innocenti F, Fabbri A, Anichini R, Tuci S, Pettina G, Vannucci F, et al. Indications of reduced pulmonary fanction in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 1994; 25: 161-168.
25. Makkar P, Gandhi M, Agrawal RP, Sabir M, Kothari RP. Ventilatory pulmonary function tests in type 1 diabetes mellitus. J Assoc Physicians India 2000; 48: 962-966.
26. Rosenecker J, Hofler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001; 6: 345-350.
27. Bell D, Collier A, Matthews DM, Cooksey EJ, McHardy GJ, Clarke BF. Are reduced lung volumes in IDDM due to defect in connective tissue. Diabetes 1988; 37: 829-831.
28. Maccioni FJ, Colebatch HJ. Lung volume and distensibility in insulin-dependent diabetes mellitus. Am Rev Respir Dis 1991; 143: 1253-1256.
29. Schnapf BM, Banks RA, Silverstein JH, Rosenbloom AL, Chesrown SE, Loughlin GM. Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. Am Rev Respir Dis 1984; 130: 930-932.
30. Cooper BG, Taylor R, Alberti KG, Gibson GJ. Lung function in patients with diabetes mellitus. Respir Med 1990; 84: 235-239.
31. Davis T, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2000; 50: 153-159.